Please provide your email address to receive an email when new articles are posted on . The FDA has updated its safety communication to remind the public, health care providers, lab personnel and lab ...

Zenosense, Inc. (ZENO) is a healthcare technology company located in Valencia, Spain. The company’s main focus is a novel hand-held point-of-care (POC) cardiac diagnostic device called MIDS Cardiac.

Even when cardiac troponin levels detected by high-sensitivity assays are within the normal range, elevations are associated with incident cardiovascular events in people without overt disease, a meta ...

Chest pain patients were discharged 26 minutes quicker when doctors received final troponin lab results via push notification to their smartphones. Delivering lab results to ED physicians via their ...

A test used by doctors in the emergency room to determine if a person is having a heart attack is now equipped to be more sensitive than ever. In addition to diagnosing heart attacks earlier, the test ...

As a cardiologist, I see this far too often: women come to us later in the course of heart disease, sometimes after weeks or even months of vague symptoms that were dismissed or misdiagnosed. We've ...

Please provide your email address to receive an email when new articles are posted on . In January, the FDA gave clearance to a next-generation troponin T assay, the first high-sensitivity troponin ...

Adding glucose level and estimated glomerular filtration rate (eGFR) to high-sensitivity cardiac troponin (hs-cTn) level testing in the emergency department (ED) is more sensitive and specific for ...

BALTIMORE, April 18, 2012 /PRNewswire/ -- Silicon BioDevices, based in Berkeley, Calif., today presented the results of a pivotal benchmark study of its digital handheld device for high-sensitivity ...

In this interview, News-Medical talks to Dr. Dana Fletcher, Martin Berner, and Robin Pettini from Siemens Healthineers about the connection between high-sensitivity troponin and heart attacks. What is ...